Findings suggest that routine urine drug screening in the ICCU could improve risk stratification, help personalize drug withdrawal support.

US health officials are proposing a new way to develop and approve custom-made treatments for people with rare and hard-to-treat conditions.

A retrospective cohort study found that beta-blocker use is associated with a decreased risk for incident HF in certain SAID populations.

Moderate-to-vigorous physical activity (MVPA) may lower the risk for cancer mortality among cancer survivors, according to a study published online Feb. 17 in J ...

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online Feb. 18 in eClinicalMedicine.

GLP1-RA use may be linked to improved overall survival, but not improved disease-free survival, in breast cancer survivors, researchers report.

Glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy was associated with reduced Parkinson disease (PD) risk.

For individuals with high BP, baduanjin, a traditional Chinese mind-body practice, can lower SBP, with effects sustained for ...

Wildfire smoke exposure during pregnancy may increase the risk for autism spectrum disorder (ASD), according to a new study.

Researchers sought to compare pre- and post-ICH blood pressure control across racial, ethnic, and social deprivation groups ...

FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.

The US Food and Drug Administration (FDA) is relaxing a long-standing drug approval requirement for common diseases.